Plunkett Research Online: Novus Therapeutics Inc

NOVUS THERAPEUTICS INC (NVUS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with .....



Novus Therapeutics Inc
Ticker: NVUS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 225-4305
Fax:
Address: 19900 MacArthur Boulevard
Suite 550
Irvine, CA 92612 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Gregory FlesherCEO/Director
Jon KuwaharaCFO/Chief Accounting Officer/Senior VP, Divisional
See More
Novus Therapeutics Inc is engaged in the biotechnology sector. As a pharmaceutical company, it is focused on the acquisition, development, and commercialization of ear, nose, and throat related products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with .....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: